Strictly Buy and Sell Set Ups Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Strictly Buy and Sell Set Ups

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Paul Kern who wrote (4176)	6/13/2005 12:15:29 PM
From: Paul Kern	Read Replies (1) of 13449

RE: ELOS FDA Clears Syneron VelaSmooth for Cellulite Treatment YOKNEAM, Israel, and TORONTO, June 13 /PRNewswire-FirstCall/ -- Syneron Medical Ltd. (Nasdaq: ELOS - News) today announces the US Food & Drug Administration (FDA) has granted 510(k) pre-marketing clearance to Syneron's VelaSmooth medical device, powered by elos, for the temporary reduction in the appearance of cellulite. The VelaSmooth also received clearance for the relief of minor muscle aches, pain and spasm and the temporary improvement of local blood circulation. The clearance of the VelaSmooth offers a new non-surgical, no downtime alternative for patients wishing to treat the appearance of cellulite. biz.yahoo.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next